A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer

NCT00952497 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Cisplatin, Capecitabine, Telatinib

Sponsor

ACT Biotech, Inc